<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39368077</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>05</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">2046-4924</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>64</Issue><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Health technology assessment (Winchester, England)</Title><ISOAbbreviation>Health Technol Assess</ISOAbbreviation></Journal><ArticleTitle>Specific phobias in children with moderate to severe intellectual disabilities: SPIRIT, an adaptation and feasibility study.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>118</EndPage><MedlinePgn>1-118</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3310/LRWD7852</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">There is a lack of interventions for specific phobia in children and adolescents with moderate to severe intellectual disabilities.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">The objectives were to: (a) develop an intervention for specific phobia, together with an intervention fidelity checklist and logic model, and evaluate candidate outcome measures, together with parents/carers and clinicians; (b) describe treatment as usual; (c) model the intervention to determine the acceptability and feasibility for all stakeholders, judge the appropriateness of outcome measures, explore recruitment pathways, and examine the feasibility and acceptability of consent and associated processes; and (d) describe factors that facilitate or challenge the intervention.</AbstractText><AbstractText Label="DESIGN" NlmCategory="UNASSIGNED">Phase 1a: using consensus methods, an Intervention Development Group was established who met to develop the intervention, review candidate outcome measures and contribute to the development of the intervention fidelity checklists and logic model. Phase 1b: a national online survey was conducted with parents and professionals to describe treatment as usual. Phase 2: a single-group non-randomised feasibility study was designed to model the intervention and to test intervention feasibility and acceptability, outcome measures and aspects of the research process.</AbstractText><AbstractText Label="SETTING" NlmCategory="UNASSIGNED">Phase 2: participants were recruited from National Health Service community child learning disabilities teams and special schools in England. Treatment was delivered in the child learning disabilities teams.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="UNASSIGNED">Children aged 5-15 years with moderate to severe learning disability and specific phobia, and their parents/carers.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="UNASSIGNED">The SPIRIT intervention comprised two half-day workshops and eight support sessions plus treatment as usual.</AbstractText><AbstractText Label="MAIN OUTCOMES" NlmCategory="UNASSIGNED">The feasibility and acceptability of the intervention and research processes, recruitment, outcome measure completion rates and acceptability, and intervention adherence. Parents completed all of the outcome measures, with very low rates of missing data. The recruitment of sites and participants was impacted by the COVID-19 pandemic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The intervention was successfully developed and modelled with 15 participants with moderate to severe learning disabilities and their parents. The intervention was judged to be feasible and acceptable by parents/carers and therapists. Parents/carers and therapists suggested minor intervention revisions.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="UNASSIGNED">Randomisation was not modelled within this feasibility study, although the majority of parents and therapists indicated that this would be acceptable.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The SPIRIT intervention and associated study processes were judged to be feasible and acceptable. The intervention requires minor revisions.</AbstractText><AbstractText Label="FUTURE WORK" NlmCategory="UNASSIGNED">The SPIRIT intervention should be tested further within a clinical trial.</AbstractText><AbstractText Label="STUDY REGISTRATION" NlmCategory="UNASSIGNED">Current Controlled Trials ISRCTN34766613.</AbstractText><AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: NIHR130177) and is published in full in <i>Health Technology Assessment</i>; Vol. 28, No. 64. See the NIHR Funding and Awards website for further award information.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gray</LastName><ForeName>Kylie M</ForeName><Initials>KM</Initials><Identifier Source="ORCID">0000-0001-6518-4240</Identifier><AffiliationInfo><Affiliation>Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Apanasionok</LastName><ForeName>Magdalena M</ForeName><Initials>MM</Initials><Identifier Source="ORCID">0000-0002-3861-3801</Identifier><AffiliationInfo><Affiliation>Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scripps</LastName><ForeName>Emma</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6140-2976</Identifier><AffiliationInfo><Affiliation>Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bunning</LastName><ForeName>Karen</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7396-9205</Identifier><AffiliationInfo><Affiliation>School of Health Sciences, University of East Anglia, Norwich, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>Christine</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-5562-8896</Identifier><AffiliationInfo><Affiliation>Foundation for People with Learning Disabilities, Colechurch House, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Filipczuk</LastName><ForeName>Malwina</ForeName><Initials>M</Initials><Identifier Source="ORCID">0009-0001-5051-9842</Identifier><AffiliationInfo><Affiliation>Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hastings</LastName><ForeName>Richard P</ForeName><Initials>RP</Initials><Identifier Source="ORCID">0000-0002-0495-8270</Identifier><AffiliationInfo><Affiliation>Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liew</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-3825-225X</Identifier><AffiliationInfo><Affiliation>South London and Maudsley NHS Foundation Trust, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McNamara</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-7280-1611</Identifier><AffiliationInfo><Affiliation>Centre for Trials Research, Cardiff University, Neuadd Meirionnydd, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nisar</LastName><ForeName>Atiyya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1996-3603</Identifier><AffiliationInfo><Affiliation>Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Playle</LastName><ForeName>Rebecca</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0002-2989-1092</Identifier><AffiliationInfo><Affiliation>Centre for Trials Research, Cardiff University, Neuadd Meirionnydd, Cardiff, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Tim</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-0072-3316</Identifier><AffiliationInfo><Affiliation>School of Psychology and Clinical Sciences, University of Reading, Berkshire, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Langdon</LastName><ForeName>Peter E</ForeName><Initials>PE</Initials><Identifier Source="ORCID">0000-0002-7745-1825</Identifier><AffiliationInfo><Affiliation>Centre for Research in Intellectual and Developmental Disabilities (CIDD), University of Warwick, Coventry, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Technol Assess</MedlineTA><NlmUniqueID>9706284</NlmUniqueID><ISSNLinking>1366-5278</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005240" MajorTopicYN="Y">Feasibility Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008607" MajorTopicYN="Y">Intellectual Disability</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010698" MajorTopicYN="Y">Phobic Disorders</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010290" MajorTopicYN="N">Parents</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="plain-language-summary" Language="eng"><AbstractText>This study was about children and adolescents who have moderate to severe learning disabilities and specific phobia. This study had two parts. In the first part, we worked with parents of young people with learning disabilities and therapists to develop a treatment for specific phobia in children and adolescents with moderate to severe learning disabilities. We also collected information about what treatment young people were currently getting. To do this, we conducted a national (United Kingdom) survey of parents/carers who have a child with a learning disability and a phobia, along with a survey of health professionals who work with children with learning disabilities. Together with parents and therapists, we developed a treatment for specific phobia in children and adolescents with moderate to severe learning disabilities. We collected information about what treatments young people received for specific phobia and found that many do not receive any treatment for their specific phobia. In the second part, we wanted to find out whether the treatment was acceptable to parents and therapists. To do this, we tried out the treatment with 15 children and adolescents. We had difficulties getting people involved in the study due to the COVID-19 pandemic. We got enough people involved to help us to work out whether the treatment was acceptable to parents and therapists. We interviewed parents and therapists to find out how they felt about the treatment and being part of the study. We also talked to therapists to ask them what they thought about the treatment. Parents told us that they liked being involved in the study and found the treatment helped them to help their children. Parents and therapists suggested some changes to the treatment to help improve it in the future. It was recommended that a larger study should be completed.</AbstractText></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ANXIETY</Keyword><Keyword MajorTopicYN="N">EXPOSURE THERAPY</Keyword><Keyword MajorTopicYN="N">FEASIBILITY</Keyword><Keyword MajorTopicYN="N">INTELLECTUAL DISABILITY</Keyword><Keyword MajorTopicYN="N">LEARNING DISABILITY</Keyword><Keyword MajorTopicYN="N">PARENT-MEDIATED</Keyword><Keyword MajorTopicYN="N">PSYCHOLOGICAL INTERVENTION</Keyword><Keyword MajorTopicYN="N">SPECIFIC PHOBIA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>6</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>5</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39368077</ArticleId><ArticleId IdType="pmc">PMC11472212</ArticleId><ArticleId IdType="doi">10.3310/LRWD7852</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Einfeld SL, Ellis LA, Emerson E. Comorbidity of intellectual disability and mental disorder in children and adolescents: a systematic review. J Intellect Dev Dis 2011;36:137–43. https://doi.org/10.1080/13668250.2011.572548</Citation><ArticleIdList><ArticleId IdType="pubmed">21609299</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerson E, Hatton C. Mental health of children and adolescents with intellectual disabilities in Britain. Br J Psychiatry 2007;191:493–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18055952</ArticleId></ArticleIdList></Reference><Reference><Citation>Dekker MC, Koot HM. DSM-IV disorders in children with borderline to moderate intellectual disability. I: prevalence and impact. J Am Acad Child Adolesc Psychiatry 2003;42:915–22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12874493</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerson E. Prevalence of psychiatric disorders in children and adolescents with and without intellectual disability. J Intellect Disabil Res 2003;47:51–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">12558695</ArticleId></ArticleIdList></Reference><Reference><Citation>Ollendick T, King NJ, Muris P. Fears and phobias in children: phenomenology, epidemiology, and aetiology. Child Adolesc Ment Health 2002;7:98–106.</Citation></Reference><Reference><Citation>Fichter M, Kohlboeck G, Quadflieg N, Wyschkon A, Esser G. From childhood to adult age: 18-year longitudinal results and prediction of the course of mental disorders in the community. Soc Psychiatry Psychiatr Epidemiol 2009;44:792–803.</Citation><ArticleIdList><ArticleId IdType="pubmed">19212695</ArticleId></ArticleIdList></Reference><Reference><Citation>Stinson FS, Dawson DA, Chou SP, Smith S, Goldstein RB, Ruan WJ, et al. The epidemiology of DSM-IV specific phobia in the USA: results from the national epidemiologic survey on alcohol and related conditions. Psychol Med 2007;37:1047–59.</Citation><ArticleIdList><ArticleId IdType="pubmed">17335637</ArticleId></ArticleIdList></Reference><Reference><Citation>Local Government Association, Association of Directors of Adult Social Services in England, NHS England. Building the Right Support: A National Plan to Develop Community Services and Close Inpatient Facilities for People With a Learning Disability and/or Autism Who Display Behaviour that Challenges, Including Those with a Mental Health Condition. London, UK: Department of Health; 2015.</Citation></Reference><Reference><Citation>Vereenooghe L, Flynn S, Hastings RP, Adams D, Chauhan U, Cooper SA, et al. Interventions for mental health problems in children and adults with severe intellectual disabilities: a systematic review. BMJ Open 2018;8:e021911. https://doi.org/10.1136/bmjopen-2018-021911</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6020952</ArticleId><ArticleId IdType="pubmed">29921688</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams TI, Lewis S, Marcham L, Palicka A. Treatment of dog phobia in young people with autism and severe intellectual disabilities: an extended case series. Contemp Behav Health Care 2018;3:1–5.</Citation></Reference><Reference><Citation>Romeo R, Molosankwe I. Economic evidence in intellectual disabilities: a review. Curr Opin Psychiatry 2010;23:427–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">20712075</ArticleId></ArticleIdList></Reference><Reference><Citation>Toms G, Totsika V, Hastings RP, Healy H. Access to services by children with intellectual disability and mental health problems: population-based evidence from the UK. J Intellect Dev Disabil 2015;40:239–47.</Citation></Reference><Reference><Citation>Buescher AV, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the United Kingdom and the United States. JAMA Pediatr 2014;168:721–8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24911948</ArticleId></ArticleIdList></Reference><Reference><Citation>Einfeld SL, Ellis LA, Doran CM, Emerson E, Horstead SK, Madden RH, Tonge BJ. Behavior problems increase costs of care of children with intellectual disabilities. J Ment Health Res Intellec Disabil 2010;3:202–9.</Citation></Reference><Reference><Citation>Doran CM, Einfeld SL, Madden RH, Otim M, Horstead SK, Ellis LA, Emerson E. How much does intellectual disability really cost? J Intellect Dev Dis 2012;37:42–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">22339044</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS England, National Institute for Health Research. NHS England’s Research Needs Assessment; 2018. URL: https://allcatsrgrey.org.uk/wp/download/commissioning/nhs-englands-research-needs-assessment-2018.pdf (accessed 24 April 2024).</Citation></Reference><Reference><Citation>NHS England, The NHS Long Term Plan; 2019. URL: www.england.nhs.uk/publication/the-nhs-long-term-plan/ (accessed 24 April 2024).</Citation></Reference><Reference><Citation>Morris C, Simkiss D, Busk M, Morris M, Allard A, Denness J, et al. Setting research priorities to improve the health of children and young people with neurodisability: a British Academy of Childhood Disability–James Lind Alliance Research Priority Setting Partnership. BMJ Open 2015;5:e006233. https://doi.org/10.1136/bmjopen-2014-006233</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4316435</ArticleId><ArticleId IdType="pubmed">25631309</ArticleId></ArticleIdList></Reference><Reference><Citation>NHS England. NHS Research Plan. London, UK: NHS England; 2017.</Citation></Reference><Reference><Citation>Chalfant A, Rapee R, Carroll L. Treating anxiety disorders in children with high functioning autism spectrum disorders: a controlled trial. J Autism Dev Disord 2007;37:1842–57.</Citation><ArticleIdList><ArticleId IdType="pubmed">17171539</ArticleId></ArticleIdList></Reference><Reference><Citation>Maskey M, Lowry J, Rodgers J, McConachie H, Parr JR. Reducing specific phobia/fear in young people with autism spectrum disorders (ASDs) through a virtual reality environment intervention. PLOS ONE 2014;9:e100374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4079659</ArticleId><ArticleId IdType="pubmed">24987957</ArticleId></ArticleIdList></Reference><Reference><Citation>Maskey M, Rodgers J, Grahame V, Glod M, Honey E, Kinnear J, et al. A randomised controlled feasibility trial of immersive virtual reality treatment with cognitive behaviour therapy for specific phobias in young people with Autism Spectrum Disorder. J Autism Dev Disord 2019;49:1912–27. https://doi.org/10.1007/s10803-018-3861-x</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6484088</ArticleId><ArticleId IdType="pubmed">30767156</ArticleId></ArticleIdList></Reference><Reference><Citation>Vigerland S, Thulin U, Ljótsson B, Svirsky L, Öst LG, Lindefors N, et al. Internet-delivered CBT for children with specific phobia: a pilot study. Cogn Behav Ther 2013;42:303–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24245708</ArticleId></ArticleIdList></Reference><Reference><Citation>McGregor KK, Berns AJ, Owen AJ, Michels SA, Duff D, Bahnsen AJ, et al. Associations between syntax and the lexicon among children with or without ASD and language impairment. J Autism Dev Disord 2012;42:35–47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3177980</ArticleId><ArticleId IdType="pubmed">21365354</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice M, Warren S, Betz S. Language symptoms of developmental language disorders: an overview of autism, Down syndrome, specific language impairment, and Williams syndrome. Appl Psycholinguist 2004;26:7–27.</Citation></Reference><Reference><Citation>Meuwese-Jongejeugd A, van Zanten B, Verschuure H, Eicchorn E, Koopman D, Bernsen R, et al. Prevalence of hearing loss in 1598 adults with an intellectual disability: cross-sectional population based study. Int J Audiol 2006;45:660–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">17118908</ArticleId></ArticleIdList></Reference><Reference><Citation>van Splunder J, Stilma JS, Bernsen RMD, Evenhuis HM. Prevalence of ocular diagnoses found on screening 1539 adults with intellectual disabilities. Ophthalmology 2004;111:1457–63.</Citation><ArticleIdList><ArticleId IdType="pubmed">15288971</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence. Mental Health Problems in People with Learning Disabilities: Prevention, Assessment and Management. London, UK: National Institute for Health and Care Excellence; 2016.</Citation><ArticleIdList><ArticleId IdType="pubmed">27683921</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton P, Palicka A, Williams TI. Treating specific phobias in young people with autism and severe learning difficulties. Cogn Behav Ther 2017;10:e21.</Citation></Reference><Reference><Citation>Chok JT, Demanche J, Kennedy A, Studer L. Utilizing physiological measures to facilitate phobia treatment with individuals with autism and intellectual disability: a case study. Behav Interv 2010;25:325–37.</Citation></Reference><Reference><Citation>Newman C, Adams K. Dog gone good: Managing dog phobia in a teenage boy with a learning disability. Br J Learn Disabil 2004;32:35–8.</Citation></Reference><Reference><Citation>Ollendick TH, King NJ. Origins of childhood fears: an evaluation of Rachman’s theory of fear acquisition. Behav Res Ther 1991;29:117–23. https://doi.org/10.1016/0005-7967(91)90039-6</Citation><ArticleIdList><ArticleId IdType="pubmed">2021373</ArticleId></ArticleIdList></Reference><Reference><Citation>Rachman S. The conditioning theory of fear acquisition: a critical examination. Behav Res Ther 1977;15:375–87.</Citation><ArticleIdList><ArticleId IdType="pubmed">612338</ArticleId></ArticleIdList></Reference><Reference><Citation>Butler G. Phobic Disorders. In Hawton K, Salkovskis PM, Kirk J, Clark DM, editors. Cognitive Behaviour Therapy for Psychiatric Problems. Oxford: Oxford University Press; 1989.</Citation></Reference><Reference><Citation>Wolpe J. The systematic desensitization treatment of neuroses. J Nerv Ment Dis 1961;132:189–203.</Citation><ArticleIdList><ArticleId IdType="pubmed">13786444</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton WW, Bienvenu OJ, Miloyan B. Specific phobias. Lancet Psychiatry 2018;5:678–86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233312</ArticleId><ArticleId IdType="pubmed">30060873</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis TE, May A, Whiting SE. Evidence-based treatment of anxiety and phobia in children and adolescents: current status and effects on the emotional response. Clin Psychol Rev 2011;31:592–602.</Citation><ArticleIdList><ArticleId IdType="pubmed">21482318</ArticleId></ArticleIdList></Reference><Reference><Citation>Ollendick T, Ollendick TH, Ost LG, Reuterskiold L, Costa N, Cederlund R, et al. One-session treatment of specific phobias in youth: a randomized clinical trial in the United States and Sweden. J Consult Clin Psychol 2009;77:504–16.</Citation><ArticleIdList><ArticleId IdType="pubmed">19485591</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahoda A, Hastings R, Hatton C, Cooper S-A, Dagnan D, Zhang R, et al. Comparison of behavioural activation with guided self-help for treatment of depression in adults with intellectual disabilities: a randomised controlled trial. Lancet Psychiatry 2017;4:909–19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5714593</ArticleId><ArticleId IdType="pubmed">29153873</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). 5th edn. Washington, DC: American Psychiatric Association; 2013.</Citation></Reference><Reference><Citation>Foundation for People with Learning Disabilities. PELICAN: Promoting Emotional Literacy in Children with Additional Needs. URL: www.learningdisabilities.org.uk/learning-disabilities/our-work/employment-education/pelican (accessed 24 April 2024).</Citation></Reference><Reference><Citation>Dagnan, D, Masson, J, Cavagin, A, Thwaites, R, Hatton, C. The development of a measure of confidence in delivering therapy to people with intellectual disabilities. Clin Psychol Psychother 2015;22:392–8. https://doi.org/10.1002/cpp.1898</Citation><ArticleIdList><ArticleId IdType="pubmed">24802005</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher RJ, Barnhill J, Cooper SA, editors. Diagnostic Manual – Intellectual Disability 2: A Textbook of Diagnosis of Mental Disorders in Persons with Intellectual Disability. 2nd edn. Kingston, NY: National Association for the Dually Diagnosed; 2017.</Citation></Reference><Reference><Citation>Silverman W, Albano A. Anxiety Disorders Interview Schedule. Oxford: Oxford University Press; 1996.</Citation></Reference><Reference><Citation>Sparrow SS, Cicchetti DV, Saulnier CA. Vineland Adaptive Behavior Scales (Vineland-3). 3rd edn. Minneapolis, MN: Pearson; 2016.</Citation></Reference><Reference><Citation>Craske M, Wittchen U, Bogels S, Stein M, Andrews G, Lebeu R. Severity Measure for Specific Phobia – Child. Washington, DC: American Psychiatric Association; 2013.</Citation></Reference><Reference><Citation>Goodman R. The extended version of the Strengths and Difficulties Questionnaire as a guide to child psychiatric caseness and consequent burden. J Child Psychol Psychiatry Allied Discip 1999;40:791–9.</Citation><ArticleIdList><ArticleId IdType="pubmed">10433412</ArticleId></ArticleIdList></Reference><Reference><Citation>Aman MG, Singh NN. Aberrant Behavior Checklist. East Aurora, NY: Slosson; 1986.</Citation></Reference><Reference><Citation>Matson J. Evaluation of Social Skills for Individuals with Severe Retardation. Los Angeles, CA: Scientific Publishers; 1995.</Citation></Reference><Reference><Citation>Gray KM, Tonge B, Einfeld S, Gruber C, Klein A. Developmental Behavior Checklist (DBC2). 2nd edn. Torrance, CA: Western Psychological Services; 2018.</Citation></Reference><Reference><Citation>Rojahn J, Rowe E, Sharber A, Hastings R, Matson J, Didden R, et al. The behavior problems inventory‐short form for individuals with intellectual disabilities: part I: development and provisional clinical reference data. J Intellect Disabil Res 2012;56:527–45.</Citation><ArticleIdList><ArticleId IdType="pubmed">22151184</ArticleId></ArticleIdList></Reference><Reference><Citation>Gevartera C, O’Reilly MF, Rojeslkia L, Sammarcoa N, Langb R, Lacionic G, et al. Comparisons of intervention components within augmentative and alternative communication systems for individuals with developmental disabilities: a review of the literature. Res Dev Disabil 2013;34:4404–14.</Citation><ArticleIdList><ArticleId IdType="pubmed">24139716</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions. BMJ 2014;348:g1687.</Citation><ArticleIdList><ArticleId IdType="pubmed">24609605</ArticleId></ArticleIdList></Reference><Reference><Citation>Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:979–83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2769032</ArticleId><ArticleId IdType="pubmed">18824488</ArticleId></ArticleIdList></Reference><Reference><Citation>Arain M, Campbell MJ, Cooper CL, Lancaster GA. What is a pilot or feasibility study? A review of current practice and editorial policy. BMC Med Res Methodol 2010;10:67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2912920</ArticleId><ArticleId IdType="pubmed">20637084</ArticleId></ArticleIdList></Reference><Reference><Citation>Bradshaw J, Gore N, Darvell C. Supporting the direct involvement of students with disabilities in functional assessment through use of Talking Mats®. Tizard Learn Disabil Rev 2018;23:111–6.</Citation></Reference><Reference><Citation>Lancaster GA, Thabane L. Guidelines for reporting non-randomised pilot and feasibility studies. Pilot Feasibility Stud 2019;5:114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6778655</ArticleId><ArticleId IdType="pubmed">31608150</ArticleId></ArticleIdList></Reference><Reference><Citation>Gale NK, Heath G, Cameron E, Rashid S, Redwood S. Using the framework method for the analysis of qualitative data in multi-disciplinary health research. BMC Med Res Methodol 2013;13:117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3848812</ArticleId><ArticleId IdType="pubmed">24047204</ArticleId></ArticleIdList></Reference><Reference><Citation>Avery KN, Williamson PR, Gamble C, Francischetto EO, Metcalfe C, Davidson P, et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open 2017;7:e013537.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5318608</ArticleId><ArticleId IdType="pubmed">28213598</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>